Dosimetric Analysis of Computed Tomography-Based Brachytherapy Planning in Carcinoma Cervix

Abstract

Background

The standard of care for locally advanced cervical cancer is concurrent chemoradiation followed by intracavitary brachytherapy (BT). BT forms an integral part of management as it improves local control and overall survival. In recent times, image-guided BT (IGBT) has been recommended as the standard of care. Computed tomography (CT) scan-based BT is a cost-effective and easily available modality for IGBT. The aim of the study was to do a dosimetric analysis of CT scan-based BT for patients with cervical cancer.

Methods

This was a retrospective study and included patients with cervical cancer treated with radical chemoradiation followed by BT. CT scan was done before every fraction after applicator placement, and CT-based planning was done for all fractions. Clinical details were abstracted from the case records, and dosimetric details were collected from the treatment planning systems. Total equivalent dose in 2 Gy per fraction (EQD2) was calculated for external beam radiation therapy and BT target volumes and organs at risk (OARs).

Results

This study included 50 patients. The mean age was 45 years. The majority of the cases were stage III. The mean high-risk clinical target volume (HRCTV) for the 1st, 2nd, and 3rd fraction was 53.1, 52.1, and 51.3 mL, respectively. Mean D90 HRCTV (dose received by 90% of the HRCTV) dose was 81.4 Gy (EQD2 10 Gy) and D2cc was 75.8 Gy (EQD2 3 Gy) for the rectum and sigmoid and 86.2 Gy (EQD2 3 Gy) for the bladder.

Conclusion

CT-based BT is a reasonable option in high-volume and low-resource settings where the availability of magnetic resonance imaging is limited. CT-based BT at every fraction can ensure proper applicator placement and aid in optimizing the dose to the target volumes and OARs.

Keywords

cervical cancer - brachytherapy - chemoradiation - image-guided brachytherapy - intracavitary brachytherapy

Authors' Contributions

All authors contributed significantly for this work.

Publikationsverlauf

Eingereicht: 19. August 2023

Angenommen: 05. April 2024

Artikel online veröffentlicht:
09. Mai 2024

• References

• 1 Mehrotra R, Yadav K. Cervical cancer: formulation and implementation of Govt of India guidelines for screening and management. Indian J Gynecol Oncol 2022; 20 (01) 4
• 2 Rodin D, Burger EA, Atun R. et al. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact. Lancet Oncol 2019; 20 (07) 915-923
• 3 Cho O, Chun M. Management for locally advanced cervical cancer: new trends and controversial issues. Radiat Oncol J 2018; 36 (04) 254-264
• 4 Lanciano RM, Won M, Coia LR, Hanks GE. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991; 20 (04) 667-676
• 5 Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys 2013; 87 (01) 111-119
• 6 Viswanathan AN, Creutzberg CL, Craighead P. et al. International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys 2012; 82 (01) 250-255
• 7 Srivastava A, Datta NR. Brachytherapy in cancer cervix: time to move ahead from point A?. World J Clin Oncol 2014; 5 (04) 764-774
• 8 Datta NR. From ‘points’ to ‘profiles’ in intracavitary brachytherapy of cervical cancer. Curr Opin Obstet Gynecol 2005; 17 (01) 35-41
• 9 Harkenrider MM, Alite F, Silva SR, Small Jr W. Image-based brachytherapy for the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2015; 92 (04) 921-934
• 10 Pötter R, Georg P, Dimopoulos JCA. et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100 (01) 116-123
• 11 Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 2005; 62 (01) 131-137
• 12 Barillot I, Horiot J-C, Maingon P, Bone-Lepinoy MC, Vaillant D, Feutray S. Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol 1994; 30 (03) 231-238
• 13 Erickson B. MRI and ultrasound guide gynecologic brachytherapy. Diagn Imaging (San Franc) 2000; 22 (12) 78-83
• 14 Mutic S, Grigsby PW, Low DA. et al. PET-guided three-dimensional treatment planning of intracavitary gynecologic implants. Int J Radiat Oncol Biol Phys 2002; 52 (04) 1104-1110
• 15 Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. Magnetic resonance image guided brachytherapy. Semin Radiat Oncol 2014; 24 (03) 181-191
• 16 Viswanathan AN, Erickson B, Gaffney DK. et al. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2014; 90 (02) 320-328
• 17 Kim SH, Choi BI, Lee HP. et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 1990; 175 (01) 45-51
• 18 Mayr NA, Tali ET, Yuh WT. et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology 1993; 189 (02) 601-608
• 19 Schmid MP, Mansmann B, Federico M. et al. Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study. Strahlenther Onkol 2013; 189 (03) 238-244
• 20 Dale RG. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. Br J Radiol 1985; 58 (690) 515-528
• 21 Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours. Int J Radiat Oncol Biol Phys 2007; 68 (02) 491-498
• 22 Mahantshetty U, Poetter R, Beriwal S. et al. IBS-GEC ESTRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer. Radiother Oncol 2021; 160: 273-284
• 23 Haie-Meder C, Pötter R, Van Limbergen E. et al; Gynaecological (GYN) GEC-ESTRO Working Group. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74 (03) 235-245
• 24 Pötter R, Haie-Meder C, Van Limbergen E. et al; GEC ESTRO Working Group. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78 (01) 67-77
• 25 Corn BW, Shaktman BD, Lanciano RM. et al. Intra- and perioperative complications associated with tandem and colpostat application for cervix cancer. Gynecol Oncol 1997; 64 (02) 224-229
• 26 Grover S, Harkenrider MM, Cho LP. et al. Image guided cervical brachytherapy: 2014 survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2016; 94 (03) 598-604
• 27 Tod M, Meredith WJ. Treatment of cancer of the cervix uteri, a revised Manchester method. Br J Radiol 1953; 26 (305) 252-257
• 28 Nag S, Cardenes H, Chang S. et al; Image-Guided Brachytherapy Working Group. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 2004; 60 (04) 1160-1172
• 29 Zolciak-Siwinska A, Kowalczyk A, Sikorska K, Bijok M, Michalski W, Gruszczynska E. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy. Brachytherapy 2018; 17 (04) 667-672
• 30 Bandyopadhyay A, Ghosh AK, Chhatui B, Das D. Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study. Rep Pract Oncol Radiother 2021; 26 (02) 170-178
• 31 Hricak H, Gatsonis C, Coakley FV. et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007; 245 (02) 491-498
• 32 Dimopoulos JC, Schard G, Berger D. et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, pathoanatomic structures, and organs at risk. Int J Radiat Oncol Biol Phys 2006; 64 (05) 1380-1388
• 33 Chatterjee A, Grover S, Gurram L, Sastri S, Mahantshetty U. Patterns of cervical cancer brachytherapy in India: results of an online survey supported by the Indian Brachytherapy Society. J Contemp Brachytherapy 2019; 11 (06) 527-533
• 34 Beriwal S, Kannan N, Kim H. et al. Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical cancer using a hybrid magnetic resonance imaging/computed tomography approach: feasibility and early results. Clin Oncol (R Coll Radiol) 2011; 23 (10) 685-690
• 35 Nesvacil N, Pötter R, Sturdza A, Hegazy N, Federico M, Kirisits C. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction. Radiother Oncol 2013; 107 (01) 75-81
• 36 Ohno T, Wakatsuki M, Toita T. et al; The Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG). Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients. J Radiat Res (Tokyo) 2017; 58 (03) 341-350
• 37 Ohno T, Noda SE, Okonogi N. et al. In-room computed tomography-based brachytherapy for uterine cervical cancer: results of a 5-year retrospective study. J Radiat Res (Tokyo) 2017; 58 (04) 543-551
• 38 Viswanathan AN, Beriwal S, De Los Santos JF. et al; American Brachytherapy Society. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy 2012; 11 (01) 47-52
• 39 Murakami N, Kasamatsu T, Wakita A. et al. CT based three dimensional dose-volume evaluations for high-dose rate intracavitary brachytherapy for cervical cancer. BMC Cancer 2014; 14: 447
• 40 Dimopoulos JC, Pötter R, Lang S. et al. Dose-effect relationship for local control of cervical cancer by magnetic resonance image-guided brachytherapy. Radiother Oncol 2009; 93 (02) 311-315
• 41 Sturdza A, Pötter R, Fokdal LU. et al. Image guided brachytherapy in locally advanced cervical cancer: improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016; 120 (03) 428-433
• 42 Tanderup K, Fokdal LU, Sturdza A. et al. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Radiother Oncol 2016; 120 (03) 441-446
• 43 Dimopoulos JC, Lang S, Kirisits C. et al. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75 (01) 56-63
• 44 Okazaki S, Murata K, Noda SE. et al. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy. J Radiat Res (Tokyo) 2019; 60 (04) 490-500
• 45 Eskander RN, Scanderbeg D, Saenz CC, Brown M, Yashar C. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring. Int J Gynecol Cancer 2010; 20 (01) 47-53